Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Pattern of Pharmacological Treatment in Subjects With Metabolic Syndrome: Findings From Isfahan Healthy Heart Program



Gharipour M1 ; Tabib AA1 ; Toghianifar N1 ; Tavassoli A1 ; Gharipour A2 ; Sarrafzadegan N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, University of Medical Sciences, Isfahan, Iran
  2. 2. Data mining Researcher, Isfahan Mathematics House, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2011

Abstract

Background: Pharmacological therapy is a critical step in the management of individuals with Metabolic Syndrome (MetS) when lifestyle modifications can not to achieve the therapeutic goals. However, it is well-documented that other than weight loss, there is no single best therapy, and the treatment should consist of treatment of individual components of the MetS. The objective of this study was to investigate treatment of individual components of the MetS among a population-based sample of individuals with the clustering of those components of the MetS. Methods: A cross-sectional population-based study, a randomly collected sample of men and women living in three counties in central Iran participating in the baseline survey of a community -based program in 2000-2001 were examined. A questionnaire was completed for all participants to collect data regarding their demographic characteristics, medical status and history of medication use. In this study we determined the association between clustering of MetS components and pharmacological treatment of cardiovascular risk factors. Findings: The most common pharmacologic agent received by individuals with MetS were beta blockers (72.8%) used for controlling high blood pressure, followed by lipid lowering agents (36%) without significant gender difference. Conclusion: Our results exhibited Beta blockers, statins, fibrates and glybenclamid are more prevalent drugs among subjects with metabolic syndrome. Further research is needed to better elucidate the compliance behavior of patients who have been diagnosed with MetS.
Related Docs
View other Related Docs
1. Sex Based Pharmacological Treatment in Patients With Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program, African Journal of Pharmacy and Pharmacology (2011)
2. The Impact of a Community Trial on the Pharmacological Treatment in the Individuals With the Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program, 2001-2007, Archives of Medical Science (2012)
3. Socioeconomic Disparities and Smoking Habits in Metabolic Syndrome: Evidence From Isfahan Healthy Heart Program, Iranian Red Crescent Medical Journal (2011)
4. Metabolic Syndrome: An Emerging Public Health Problem in Iranian Women: Isfahan Healthy Heart Program, International Journal of Cardiology (2008)
5. Determinants of Changes in Metabolic Syndrome Components in a 12-Year Cohort of Iranian Adults, Metabolic Syndrome and Related Disorders (2019)
6. Association of Glycaemic Index and Glycaemic Load With Metabolic Syndrome in an Iranian Adult Population: Isfahan Healthy Heart Program, Nutrition and Dietetics (2017)
7. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
8. Apopulation-Based Metabolic Syndrome Risk Score and Its Determinants: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2014)
Experts (# of related papers)
View all Related Experts
Roya Kelishadi (105)
Nizal Sarrafzadegan (100)
Other Related Docs
9. First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East: The National Survey of Risk Factors for Noncommunicable Diseases of Iran, Diabetes Care (2009)
10. Relationship Between Legumes Consumption and Metabolic Syndrome: Findings of the Isfahan Healthy Heart Program, ARYA Atherosclerosis (2014)
11. Anxiety But Not Depression Is Associated With Metabolic Syndrome: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2017)
12. Metabolic Syndrome in Iranian Elderly, ARYA Atherosclerosis (2012)
13. Multiparity and Risk of Metabolic Syndrome: Isfahan Healthy Heart Program, Metabolic Syndrome and Related Disorders (2009)
14. Relationship Between Metabolic Syndrome and Its Components With Psychological Distress, International Journal of Endocrinology (2014)
15. Consumption of Sugar-Sweetened Beverages in Relation to the Metabolic Syndrome Among Iranian Adults, Obesity Facts (2012)
16. The Metabolic Syndrome in Hypertensive and Normotensive Subjects: The Isfahan Healthy Heart Programme, Annals of the Academy of Medicine Singapore (2005)
17. The Impact of Obesity on Hypertension and Diabetes Control Following Healthy Lifestyle Intervention Program in a Developing Country Setting, Journal of Research in Medical Sciences (2011)
18. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
19. Evaluating the Relation Between Metabolic Syndrome and Its Components With Low Ankle to Brachial Index in an Iranian Population, Journal of Isfahan Medical School (2011)
20. Prevalence of Metabolic Syndrome According to Atpiii and Idf Criteria in the Iranian Population, Koomesh (2012)
21. Anthropometric Indices Predicting Incident Type 2 Diabetes in an Iranian Population: The Isfahan Cohort Study, Diabetes and Metabolism (2013)
22. Establishment of Health Clinics As Mass Screening and Referral Systems for Chronic Non-Communicable Diseases in Primary Health Care, International Journal of Preventive Medicine (2012)
23. Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The Caspian Iii Study, International Journal of Endocrinology (2013)
24. Metabolic Syndrome and Health-Related Quality of Life in Iranian Population, Journal of Research in Medical Sciences (2011)
25. Outcomes of a Comprehensive Healthy Lifestyle Program on Cardiometabolic Risk Factors in a Developing Country: The Isfahan Healthy Heart Program, Archives of Iranian Medicine (2013)
26. Evaluation of Heart Rate Recovery and Exercise Capacity in Individuals With and Without Metabolic Syndrome, Journal of Isfahan Medical School (2011)
27. Metabolic Syndrome and the Risk of Ischemic Stroke, Journal of Stroke and Cerebrovascular Diseases (2017)
28. Socioeconomic Determinants and Metabolic Syndrome: Results From the Isfahan Healthy Heart Program, Acta Biomedica (2016)
29. Left Ventricular Diastolic Function in Subjects With Metabolic Syndrome: Isfahan Cohort Study, Iranian Heart Journal (2013)
30. Low-Density Lipoprotein Cholesterol and Metabolic Syndrome in an Iranian High-Risk Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
31. Levels of Lipids and Apolipoproteins in Three Cultures, Atherosclerosis (2009)
32. Sex Based Levels of C-Reactive Protein and White Blood Cell Count in Subjects With Metabolic Syndrome: Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2013)
33. Evaluation of Heart Rate Reserve and High-Sensitivity C-Reactive Protein in Individuals With and Without Metabolic Syndrome in Isfahan, Iran, ARYA Atherosclerosis (2012)
34. Effects of Recommendations to Follow the Dietary Approaches to Stop Hypertension (Dash) Diet V. Usual Dietary Advice on Childhood Metabolic Syndrome: A Randomised Cross-Over Clinical Trial, British Journal of Nutrition (2013)
35. Association Between Sleep Duration and Metabolic Syndrome in a Population-Based Study: Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2011)
36. Structural Role of Perceived Benefits and Barriers in Receiving Macronutrients in Women With Metabolic Syndrome: A Path Analysis Study, Journal of Isfahan Medical School (2013)
37. Circulating Advanced Oxidation Protein Products (Aopps) Increases the Risk of Metabolic Syndrome Among Adults: A Systematic Review and Meta-Analysis, International Journal of Diabetes in Developing Countries (2023)
38. Metabolic Syndrome in Iranian Youths: A Population-Based Study on Junior and High Schools Students in Rural and Urban Areas, Journal of Diabetes Research (2013)
39. How Does the Impact of a Community Trial on Cardio-Metabolic Risk Factors Differ in Terms of Gender and Living Area? Findings From the Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2012)
40. Assessing Body Shape Index As a Risk Predictor for Cardiovascular Diseases and Metabolic Syndrome Among Iranian Adults, Nutrition (2014)
41. Correlation of Circulating Inflammatory Markers, Ghrelin, Adiponectin With Obesity Indices in Subjects With Metabolic Syndrome, Pakistan Journal of Medical Sciences (2013)
42. Comparing Heart Rate Reserve and High-Sensitivity C-Reactive Protein in Patients With and Without Metabolic Syndrome, Journal of Isfahan Medical School (2015)
43. Dietary Patterns in Relation to Lipid Profiles Among Iranian Adults, Journal of Cardiovascular and Thoracic Research (2019)
44. Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (Epicamp Study): A Double-Blind, Randomized Clinical Trial, PPAR Research (2013)
45. Appropriate Cut-Off Values of Waist Circumference to Predict Cardiovascular Outcomes: 7-Year Follow-Up in an Iranian Population, Internal Medicine (2012)
46. Metabolic Syndrome in Menopausal Transition: Isfahan Healthy Heart Program, a Population Based Study, Diabetology and Metabolic Syndrome (2010)
47. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
48. The Relationship Between Hematologic Variables and Metabolic Syndrome, Iranian Heart Journal (2011)
49. Improving Physical Activity and Metabolic Syndrome Indicators in Women: A Transtheoretical Model‑Based Intervention, International Journal of Preventive Medicine (2015)
50. Metabolic Syndrome and Associated Factors in Iranian Children and Adolescents: The Caspian-V Study, Journal of Cardiovascular and Thoracic Research (2018)